|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
1R21CA218976-01
|
$199,013
|
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Role of NFxB/HIF2a axis in renal cell carcinoma progression
|
5K08CA178168-05
|
$175,163
|
|
ABEL, E
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Postmenopausal women's alcohol study
|
ZIA CP000101-10336
|
$43,293
|
|
Abnet, Christian
|
DCEG (NCI)
|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185-10318
|
$18,664
|
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185-10361
|
$31,091
|
|
Abnet, Christian
|
DCEG (NCI)
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
1R21CA214102-01A1
|
$185,963
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Aerobic Exercise for Smokers with Depressive Symptomatology
|
5R01CA173551-05
|
$509,755
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Li-Fraumeni Syndrome in Brazil
|
ZIA CP010144-10769
|
$12,981
|
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
3R01CA171651-05S1
|
$46,696
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Center for Multiple Myeloma Nanotherapy
|
3U54CA199092-03S1
|
$29,864
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
5R01CA171651-05
|
$439,171
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-03
|
$2,224,884
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
A practical and versatile high-resolution 3D dosimetry system for clinical use
|
1R41CA217421-01A1
|
$299,962
|
|
ADAMOVICS, JOHN
|
HEURIS, INC.
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-03
|
$514,474
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
|
1R01CA211648-01A1
|
$429,211
|
|
ADLI, MAZHAR
|
UNIVERSITY OF VIRGINIA
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
1R03CA212798-01
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Novel Combinatorial Therapeutic Approach for Prostate Cancer
|
1R03CA219336-01
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
2R01CA140368-06
|
$369,313
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
3R01CA195708-04S1
|
$94,087
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-04
|
$382,753
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
|
1K08CA218420-01
|
$177,120
|
|
AGUIRRE, ANDREW
|
DANA-FARBER CANCER INST
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
1R01CA218024-01
|
$445,511
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
|
5R01CA164964-04
|
$468,512
|
|
AHN, JIYOUNG
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
|
2R01CA134633-05
|
$540,493
|
|
AHRENS, ERIC
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-04
|
$398,393
|
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-02
|
$462,880
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction
|
5R01CA172741-05
|
$279,793
|
|
AJANI, JAFFER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Development of novel gallium-68 bisphosphonate for imaging bone metastases in prostate cancer
|
1R43CA221580-01
|
$225,000
|
|
ALEXOFF, DAVID
|
FIVE ELEVEN PHARMA, INC.
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
1F30CA220847-01
|
$49,044
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-04
|
$584,480
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Multicellular Cancer Cell Cluster Extravasation through Angiopellosis
|
1F31CA217153-01A1
|
$34,660
|
|
ALLEN, TYLER
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
5R01CA182076-04
|
$349,513
|
|
ALLEN, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-03
|
$378,171
|
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
|
Targeting defective DNA repair for the prevention of BRCA1-associated cancers
|
5K22CA181550-03
|
$162,000
|
|
ALLI, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-03
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-04
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-03
|
$362,569
|
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-02
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Cell-cell communications create robust collective immunological responses
|
ZIA BC 011728
|
$400,107
|
$100,027
|
Altan-Bonnet, Gregoire
|
CCR (NCI)
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-03
|
$704,509
|
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Tumor Plasticity
|
1R35CA220446-01
|
$900,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-08
|
$1,239,835
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
5R01CA169134-05
|
$312,942
|
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
3P01CA151135-05S1
|
$300,001
|
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$244,121
|
$73,236
|
Ambs, Stefan
|
CCR (NCI)
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$519,415
|
|
Ambs, Stefan
|
CCR (NCI)
|
|
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
|
1R21CA213114-01A1
|
$170,738
|
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
Total relevant funding to Interferon for this search: $7,463,584
|